Generation of IL-2-dependent cytolytic T lymphocytes (CTLs) with altered TCR responses derived from antigen-dependent CTL clones

Journal of Immunology

Volumn 162, Issue 11, 1999, Pages 6466-6472

  Gullo, Charles A ^c   Esser, Mark T ^a,c   Fuller, Claudette L ^c   Braciale, Vivian Lam ^b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; INTERLEUKIN 2; PERFORIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNOREACTIVITY; IMMUNOREGULATION; INFLUENZA VIRUS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, VIRAL; CELL CULTURE TECHNIQUES; CELL DIVISION; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; INFLUENZA A VIRUS; INTERFERON TYPE II; INTERLEUKIN-2; LETHAL DOSE 50; LEUKEMIA L1210; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033152660     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Lee, R. K., J. Spielman, D. Y. Zhao, K. J. Olsen, and E. R. Podack. 1996. Perforin, Fas ligand, and TNF are the major cytotoxic molecules used by lymphokine-activated killer cells. J. Immunol. 157:1919.
2. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
3. Zheng, L., G. Fisher, R. Miller, J. Peschon, D. Lynch, and M. Lenardo. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377: 348.
4. Clark, W. R., C. M. Walsh, A. A. Glass, M. T. Huang, R. Ahmed, and M. Matloubian. 1995. Cell-mediated cytotoxicity in perforin-less mice. Int. Rev. Immunol. 13:1.
5. Lynch, D. H., F. Ramsdell, and M. R. Alderson. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16:569.
6. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16:39.
7. Walsh, C. M., M. Matloubian, C. C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, M. T. Huang, J. D. Young, R. Ahmed, and W. R. Clark. 1994. Immune function in mice lacking the perform gene. Proc. Natl. Acad. Sci. USA 91:10854.
8. Kagi, D., P. Seiler, J. Pavlovic, B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1995. The roles of perform- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25: 3256.
9. Swain, S. L. 1991. Lymphokines and the immune response: the central role of interleukin-2. Curr. Opin. Immunol. 3:304.
10. Gillis, S., A. E. Gillis, and C. S. Henney. 1981. Monoclonal antibody directed against interleukin 2: inhibition of T lymphocyte mitogenesis and the in vitro differentiation of alloreactive cytolytic T cells. J. Exp. Med. 154:983.
11. Lenardo, M. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858.
12. Abbas, A. K., V. Refaeli, L. V. Parijs, C. A. London, and J. Tschopp. 1998. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8:615.
13. Schorle, H., T. Holtschke, T. Hunig, A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621.
14. Horak, I., J. Lohler. A. Ma, and K. A. Smith. 1995. Interleukin-2-dencient mice: a new model to study autoimmunity and self-tolerance. Immunol. Rev. 148:35.
15. Andrew, M. E., V. L. Braciale, and T. J. Braciale. 1984. Regulation of IL-2 receptor expression on murine CTL clones. J. Immunol. 132:839.
16. Andrew, M. E., V. L. Braciale, T. J. Henkel, J. A. Hatch, and T. J. Braciale. 1985. Stable expression of cytolytic activity by influenza virus-specific CTLs. J. Immunol. 135:3520.
17. Andrew, M. E., A. M. Churilla, T. R. Malek, V. L. Braciale, and T. J. Braciale. 1985. Activation of virus-specific CTL clones: antigen-dependent regulation of IL-2 receptor expression. J. Immunol. 134:920.
18. Nelson, B. H., J. D. Lord, and P. D. Greenberg. 1994. Cytoplasmic domains of the interleukin-2 receptor β- and γ-chains mediate the signal for T-cell proliferation. Nature 369:333.
19. Nakamura, Y., S. M. Russell, S. A. Mess, M. Friedmann, M. Erdos, C. Francois, Y. Jacques, S. Adelstein, and W. J. Leonard. 1994. Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signaling. Nature 369:330.
20. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
21. Walsh, C. M., A. A. Glass, V. Chiu, and W. R. Clark. 1994. The role of the Fas lytic pathway in a perforin-less CTL hybridoma. J. Immunol. 153:2506.
22. Henkel, T. J., V. L. Braciale, and T. J. Braciale. 1987. Anti-TCR antibodies fail to inhibit specific lysis by CTL clones but activate lytic activity for irrelevant targets. J. Immunol. 138:1221.
23. Andrew, M., V. Braciale, and T. Braciale. 1985. Lymphokine receptor expression, proliferation, and functional differentiation in cloned cytotoxic T lymphocytes. In T Cell Clones. H. V. Boehmer and W. Haas, eds. Elsevier Science Publishers, Oxford, U.K., p. 119.
24. Braciale, T. J., M. T. Sweetser, L. A. Morrison, D. J. Kittlesen, and V. L. Braciale. 1989. Class I major histocompatibility complex-restricted cytolytic T lymphocytes recognize a limited number of sites on the influenza hemagglutinin. Proc. Natl. Acad. Sci. USA 86:277.
25. Bodmer, H. C., R. M. Pemberton, J. B. Rothbard, and B. A. Askonas. 1988. Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein. Cell 52:253.
26. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J. Exp. Med 180:1273.
27. Lukacher, A. E., V. L. Braciale, and T. J. Braciale. 1984. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J. Exp. Med. 160:814.
28. Andrew, M. E., and T. J. Braciale. 1981. Antigen-dependent proliferation of cloned continuous lines of H-2-restricted influenza virus-specific CTLs. J. Immunol. 127:1201.
29. Gnarra, J. R., and V. H. Engelhard. 1986. Derivation of cytotoxic T cell lines that express TCR but exhibit reversible loss of stable antigen binding. J. Immunol. 137:3057.
30. + cytotoxic T lymphocytes by interleukin-2. Science 238:344.
31. Lin, Y. L., and B. A. Askonas. 1981. Biological properties of an influenza A virus-specific killer T cell clone: inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. J. Exp. Med. 154:225.
32. Simon, M. M., H. U. Weltzien, H. J. Buhring, and K. Eichmann. 1984. Aged murine killer T-cell clones acquire specific cytotoxicity for P815 mastocytoma cells. Nature 308:367.
33. Esser, M. T., B. Krishnamurthy, and V. L. Braciale. 1996. Distinct T cell receptor signaling requirements for perform-or FasL-mediated cytotoxicity. J. Exp. Med 183:1697.
34. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. J. Immunol. 126:1614.
35. Bismuth, G., J. L. Moreau, G. Somme, M. Duphot, A. Dautry-Varsat, R. J. Robb, and J. Theze. 1985. Regulation of inteileukin 2 (IL2) receptor expression as an inducing signal for the expression of its own receptor on a murine T helper cell line. Eur. J. Immunol. 15:723.
36. + T lymphocyte clones. J. Immunol. 158:5612.
37. McDermott, M. R., A. E. Lukacher, V. L. Braciale, T. J. Braciale, and J. Bienenstock. 1987. Characterization and in vivo distribution of influenza-virus-specific T-lymphocytes in the murine respiratory tract. Am. Rev. Respir. Dis. 135:245.
38. + Tcl cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines. J. Exp. Med. 182:1505.
39. Lynch, D. H., and R. E. Miller. 1994. Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo. J. Exp. Med 179:31.
40. Gately, M. K., B. B. Desai, A. G. Wolitzky, P. M. Quinn, C. M. Dwyer, F. J. Podlaski, P. C. Familletti, F. Sinigaglia, R. Chizzonite, U. Gubler, and A. S. Stern. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147:874.
41. + Tcl Cells induced by IL-4 retained inflammation and perform and Fas cytotoxicity but compromised long-term killing of tumor cells. J. Immunol. 159:606.
42. + T cells. Eur. J. Immunol. 26:2263.
43. Van Parijs, L., A. Biuckians, A. Ibragimov, F. W. Alt, D. M. Willerford, and A. K. Abbas. 1997. Functional responses and apoptosis of CD25 (IL-2Rα)-deficient T cells expressing a transgenic antigen receptor. J. Immunol. 158:3738.
44. Kennedy, M. K., and L. S. Park. 1996. Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex. J. Clin. Immunol. 16:134.
45. 2+ signaling modulates cytolytic T lymphocyte effector functions. J. Exp. Med. 187:1057.
46. Otten, G., D. B. Wilde, M. B. Prystowsky, J. S. Olshan, H. Rabin, L. E. Henderson, and F. W. Fitch. 1986. Cloned helper T lymphocytes exposed to interleukin 2 become unresponsive to antigen and concanavalin A but not to calcium ionophore and phorbol ester. Eur. J. Immunol. 16:217.